Article 1Texas Physician/Researchers Case Series Finds Reduction in COVID-19 Hospitalization by 87.6% & Death 74.9%: A group of Texas-based providers, including physicians, some highly published,…
CORRECTION: The following graphic replaces the graphic in the video at 5:44. Click here to view original article Dr. Ron Brown of Waterloo University talks…
Article 1: Italian-led Ivermectin Meta-Analysis: Is it Time to Consider the Generic Low Cost Option to Help Treat COVID-19? A group of six critical care…
Shabnam Palesa Mohamed: Activist. journalist, mediator (LLB). Founder of SAHARI and THJ CEO, discusses state of Ivermectin in South Africa. We discuss the twists and…
We talk with Dr. Kedar about rural research initiatives and the impact Covid-19 has had in bringing advanced research to them. Dr. Kedar specializes in…
An interview with Dr. Tess Lawrie. We discuss the ongoing saga surrounding her meta-analysis on Ivermectin studies for the safety and efficacy against Covid-19. We…
Today we’ll be touching on a tough subject, Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord. Essentially, the immune…
We sit down with Sam Searcy to talk about his Company Clinistart, and innovative cloud-based service providers designed to accelerate clinical trial site activation and…
Article 1 Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study: Johnson & Johnson, announced that the…
Article 1:Pharmacy Queues Growing in Bulgaria as Ivermectin is Made Available:The drug Huvemek, which contains the active ingredient ivermectin, is of great interest in hundreds…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
